Heß, G., & Witzens-Harig, M. (2017). Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus. Leukemia and lymphoma, 58(12), . https://doi.org/10.1080/10428194.2017.1326034
Chicago-Zitierstil (17. Ausg.)Heß, Georg, und Mathias Witzens-Harig. "Health-related Quality of Life Data from a Phase 3, International, Randomized, Open-label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma Treated with Ibrutinib Versus Temsirolimus." Leukemia and Lymphoma 58, no. 12 (2017). https://doi.org/10.1080/10428194.2017.1326034.
MLA-Zitierstil (9. Ausg.)Heß, Georg, und Mathias Witzens-Harig. "Health-related Quality of Life Data from a Phase 3, International, Randomized, Open-label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma Treated with Ibrutinib Versus Temsirolimus." Leukemia and Lymphoma, vol. 58, no. 12, 2017, https://doi.org/10.1080/10428194.2017.1326034.